Human Genome Epidemiology Literature Finder
Pharmacogenomics
Records 1 - 30 (of 635 Records) |
Query Trace: Cisplatin[original query] |
---|
BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. Journal of the National Cancer Institute 2023 9 . Michael P Randall, Laura E Egolf, Zalman Vaksman, Minu Samanta, Matthew Tsang, David Groff, J Perry Evans, Jo Lynne Rokita, Mehdi Layeghifard, Adam Shlien, John M Maris, Sharon J Diskin, Kristopher R Bos |
Molecular pathology and clinical treatment of independent HPV primary serous carcinoma of the uterine cervix (USCC): A case report. Clinical case reports 2023 9 11 (9): e7833. Lina Niu, Fangying Ruan, Qisheng Yang, Chaoran Xia, Tao Xu, Fei Dong, Lizhen Zhang, Sheng Guo, Weiqin Lv, Junxia Wang, Yun Sha |
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. Annals of oncology : official journal of the European Society for Medical Oncology 2023 8 . H A Parsons, T Blewett, X Chu, S Sridhar, K Santos, K Xiong, V G Abramson, A Patel, J Cheng, A Brufsky, J Rhoades, J Force, R Liu, T A Traina, L A Carey, M F Rimawi, K D Miller, V Stearns, J Specht, C Falkson, H J Burstein, A C Wolff, E P Winer, N Tayob, I E Krop, G M Makrigiorgos, T R Golub, E L Mayer, V A Adalsteinss |
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO precision oncology 2023 7 7 e2300095. Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew I Milowsky, Matthew D Gals |
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel. Biomarker research 2023 7 11 (1): 73. Jessica D Lang, Tuong Vi V Nguyen, Maren K Levin, Page E Blas, Heather L Williams, Esther San Roman Rodriguez, Natalia Briones, Claudius Mueller, William Selleck, Sarah Moore, Victoria L Zismann, William P D Hendricks, Virginia Espina, Joyce O'Shaughnes |
Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration-induced nephropathy. British journal of clinical pharmacology 2023 7 . Yuki Mitarai, Ryosuke Tanino, Kazuhisa Nakashima, Takamasa Hotta, Takeshi Isobe, Yukari Tsuba |
Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant NSCLC. Cancer research and treatment 2023 6 . Beung-Chul Ahn, Charny Park, Moon Soo Kim, Jong Mog Lee, Jin Ho Choi, Hyae Young Kim, Geon Kook Lee, Namhee Yu, Youngjoo Lee, Ji-Youn H |
A pilot exome sequencing study suggests that germline variants influence methotrexate-induced toxicities in pediatric patients with localized osteosarcoma. Pediatric blood & cancer 2023 6 e30501. Francesca Minnai, Sara Noci, Nunzia Mangano, Loris De Cecco, Cristina Meazza, Monica Terenziani, Maura Massimino, Francesca Colom |
Association of MLH1-93G>A polymorphisms toward lung cancer susceptibility and its association with clinical outcome in North Indian patients treated with platinum-based chemotherapy. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S0. Sidhartha Singh, Navneet Singh, Manoj Baranwal, Siddharth Shar |
ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
Comprehensive Analysis Identifies the PPAR-Targeted Genes Associated with Ovarian Cancer Prognosis and Tumor Microenvironment. PPAR research 2023 5 2023 6637414. Xiao-Fei Leng, Gao-Fa Wang, Hao Yin, Feng Wei, Kang-Kang Zeng, Yi-Qun Zha |
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers. Nature communications 2023 4 14 (1): 1958. Ter Brugge Petra, Moser Sarah C, Bièche Ivan, Kristel Petra, Ibadioune Sabrina, Eeckhoutte Alexandre, de Bruijn Roebi, van der Burg Eline, Lutz Catrin, Annunziato Stefano, de Ruiter Julian, Masliah Planchon Julien, Vacher Sophie, Courtois Laura, El-Botty Rania, Dahmani Ahmed, Montaudon Elodie, Morisset Ludivine, Sourd Laura, Huguet Léa, Derrien Heloise, Nemati Fariba, Chateau-Joubert Sophie, Larcher Thibaut, Salomon Anne, Decaudin Didier, Reyal Fabien, Coussy Florence, Popova Tatiana, Wesseling Jelle, Stern Marc-Henri, Jonkers Jos, Marangoni Elisabet |
Genetic variation in organic cation transporters and considerations in drug development. Expert opinion on drug metabolism & toxicology 2023 4 1-16. Manthena V S Var |
Clinical and genome-wide association analysis of chemoradiation-induced hearing loss in nasopharyngeal carcinoma. Human genetics 2023 4 . He Yong-Qiao, Luo Lu-Ting, Wang Tong-Min, Xue Wen-Qiong, Yang Da-Wei, Li Dan-Hua, Diao Hua, Xiao Ruo-Wen, Deng Chang-Mi, Zhang Wen-Li, Liao Ying, Wu Yan-Xia, Wang Qiao-Ling, Zhou Ting, Li Xi-Zhao, Zheng Xiao-Hui, Zhang Pei-Fen, Zhang Shao-Dan, Hu Ye-Zhu, Sun Ying, Jia Wei-H |
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma. Cancer research communications 2023 3 2 (11): 1418-1425. Christenson Eric S, Lim Su Jin, Durham Jennifer, De Jesus-Acosta Ana, Bever Katherine, Laheru Daniel, Ryan Amy, Agarwal Parul, Scharpf Robert B, Le Dung T, Wang H |
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study. European journal of cancer (Oxford, England : 1990) 2023 3 185 83-93. Saito Ryota, Sugawara Shunichi, Ko Ryo, Azuma Koichi, Morita Ryo, Maemondo Makoto, Oizumi Satoshi, Takahashi Kazuhisa, Kagamu Hiroshi, Tsubata Yukari, Seike Masahiro, Kikuchi Toshiaki, Okamoto Isamu, Satoshi Morita, Asahina Hajime, Tanaka Kentaro, Sugio Kenji, Kobayashi Kunihi |
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. medRxiv : the preprint server for health sciences 2023 3 . Parsons Heather A, Blewett Timothy, Chu Xiangying, Sridhar Sainetra, Santos Katheryn, Xiong Kan, Abramson Vandana G, Patel Ashka, Cheng Ju, Brufsky Adam, Rhoades Justin, Force Jeremy, Liu Ruolin, Traina Tiffany A, Carey Lisa A, Rimawi Mothaffar F, Miller Kathy D, Stearns Vered, Specht Jennifer, Falkson Carla, Burstein Harold J, Wolff Antonio C, Winer Eric P, Tayob Nabihah, Krop Ian E, Makrigiorgos G Mike, Golub Todd R, Mayer Erica L, Adalsteinsson Viktor |
Pyroptosis-based risk score predicts prognosis and drug sensitivity in lung adenocarcinoma. Open medicine (Warsaw, Poland) 2023 3 18 (1): 20230663. Jiang Zhengsong, Wang Xiang, Huang Jinghan, Li Guoyin, Li Shang |
Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China. Functional & integrative genomics 2023 3 23 (2): 85. Zhou Wenqian, Guo Jinping, Li Yujie, Ma Xiaoya, Yang Shuangyu, Wei Jie, Zhang Huan, Zhang Shanshan, Jin Tian |
Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children. Therapeutic drug monitoring 2023 3 . Siemens Angela, Brooks Beth, Rassekh S Rod, Meijer Annelot J M, van den Heuvel-Eibrink Mary M, Xu Wei, Loucks Catrina M, Ross Colin J D, Carleton Bruce C, |
Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer. Clinics and research in hepatology and gastroenterology 2023 2 47 (3): 102091. Ceylan Furkan, Guven Deniz Can, Taban Hakan, Aktepe Oktay, Sahin Taha Koray, Kilickap Sadettin, Turker Alev, Hamaloglu Erhan, Karakoc Derya, Isik Aynur, Akyol Aytekin, Yalcin Suayib, Dizdar Om |
Efficacy of adjuvant chemotherapy in stage II/III NSCLC with EGFR mutation. The Thoracic and cardiovascular surgeon 2023 2 . Matsunaga Takeshi, Takamochi Kazuya, Hattori Aritoshi, Fukui Mariko, Suzuki Ken |
Systematic Review and Meta-Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum-Based Chemotherapy. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2023 2 . Hong Daniel Z, Ong Thaned C C, Timbadia Dhayan P, Tan Hui T A, Kwa Eunice D, Chong Wan Q, Goh Boon C, Loh Woei S, Loh Kwok S, Tan Ene C, Tay Joshua |
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ precision oncology 2024 4 8 (1): 87. Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada Likasitwatanakul, Orsolya Rusz, Istvan Csabai, Michael Cecchini, Yasmine Baca, Andrew Elliot, Peter Enzinger, Harshabad Singh, Jessalyn Ubellaker, Jean-Bernard Lazaro, James M Cleary, Zoltan Szallasi, Nilay S Set |
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis. Cancer pathogenesis and therapy 2024 4 2 (2): 81-90. Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zh |
TGF-?-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer. Oncology research 2024 1 32 (2): 373-391. Jianfa Wu, Qianyi Liao, L I Zhang, Suqin Wu, Zhou L |
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. Cell death discovery 2024 1 10 (1): 5. Chae Min Lee, Yeseong Hwang, Jae Woong Jeong, Minki Kim, Janghee Lee, Soong June Bae, Sung Gwe Ahn, Sungsoon Fa |
Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2024 1 15 (12): 7013-7023. Yalei Zhang, Yan Hao, Hui Pan, Hongbo Zheng, Jiaqi Zh |
Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma. International journal of molecular sciences 2024 1 25 (1): . Cita Zupanc, Alenka Franko, Danijela Štrbac, Viljem Kova?, Vita Dolžan, Katja Gori? |
Identification of potential crucial genes and therapeutic targets for epilepsy. European journal of medical research 2024 1 29 (1): 43. Shitao Wang, Zhenrong Xie, Tian Jun, Xuelu Ma, Mengen Zhang, Feng Rao, Hui Xu, Jinghong Lu, Xiangqian Ding, Zongyou |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: